Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06637189
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A. (PPDUO)
Sponsor: Ginefiv
Conditions
Blastocyst Embryo Fertilization in Vitro Oocyte Oocyte Retrieval PGT-A Stimulation in the Ovary
Interventions
Ganirelix Medroxyprogesterone Acetate 10 MG
Updated 1 time since 2024 Last updated: Oct 10, 2024 Started: Oct 15, 2024 Primary completion: Jun 15, 2025 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Blastocyst and Embryo, this trial is actively recruiting participants. The trial is conducted by Ginefiv and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Ginefiv
- Theramex
Data source: Ginefiv
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.